SCHEMBL17703228

SCHEMBL17703228

N#Cc1ccc2c(c1)c1cc(-c3ccc4c(c3)Oc3cc(-c5cccc(-c6ccncc6)n5)ccc3C4(c3ccccc3)c3ccccc3)ccc1n2-c1ccccc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 1/20 0.32
▸ ROCK2 O75116 1/20 0.32
▸ ROCK1 Q13464 1/20 0.32
▸ ALDH1A3 P47895 1/20 0.31
▸ ABCG2 Q9UNQ0 1/20 0.30
▸ TNKS2 Q9H2K2 1/20 0.30
▸ JAK2 O60674 1/20 0.30
▸ PRKD3 O94806 1/20 0.30
▸ ABL1 P00519 1/20 0.30
▸ EGFR P00533 1/20 0.30
▸ ERBB2 P04626 1/20 0.30
▸ LCK P06239 1/20 0.30
▸ CDK1 P06493 1/20 0.30
▸ CSF1R P07333 1/20 0.30
▸ LYN P07948 1/20 0.30
▸ RET P07949 1/20 0.30
▸ KIT P10721 1/20 0.30
▸ FGFR1 P11362 1/20 0.30
▸ FER P16591 1/20 0.30
▸ FLT1 P17948 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17703213 0.89 MYC (0.40) ALDH1A3ABCG2JAK2PRKD3ABL1
SCHEMBL17703222 0.89 MYC (0.39) ALDH1A3ABCG2JAK2PRKD3ABL1
SCHEMBL17703212 0.87 MAPT (0.38) ABCG2TNKS2CLK4
SCHEMBL17704068 0.86 ABCC9 (0.35) SCN9AROCK2ROCK1ALDH1A3ABCG2
SCHEMBL17703219 0.86 ABCG2 (0.34) ALDH1A3ABCG2JAK2PRKD3ABL1
SCHEMBL17703204 0.85 ALDH1A3 (0.35) ALDH1A3JAK2PRKD3ABL1EGFR
SCHEMBL17704035 0.85 ROCK2 (0.32) ROCK2ROCK1TNKS2ABL1FLT3
SCHEMBL17704046 0.85 CYP11B2 (0.39) SCN9AABCG2FLT3
SCHEMBL17704042 0.85 GRM5 (0.38) ABCG2
SCHEMBL17703208 0.85 G6PD (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9722187-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-01 — — US disclosed
US-9722187-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-01 — — US disclosed
US-20160118599-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-28 — — US disclosed
US-20160118599-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118599-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, AOX1, CYP1A1 SCN9A 1446/4885ROCK2 4590/4885ROCK1 3889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback